nMRCGP exam update - Evidence for aspirin use
Current situation. Read more
It found patients given low-dose theophylline add-on therapy or the leukotrine receptor antagonist montelukast for asthma had lower cardiovascular disease blood risk factors.
Both drugs are recommended by British Thoracic Society/SIGN guidelines for asthma patients who do not respond to long acting beta-2 agonists.
The study included 489 patients aged from 15-79 years who were diagnosed with asthma, but had an FEV1 greater than 50 per cent.
Dr Steve Holmes, Somerset GP and General Practice Airways Group (GPIAG) chairman said: 'This study looked very much at surrogate markers rather than actual outcomes.'
Comment below and tell us what you thinkCurrent situation. Read more
Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more
Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more
Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more
Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more
Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more
Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more
Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more
Comments
Only registered users may comment. Log in now or register for a free account.